Cited by 559Diabetes Management and ResearchDiabetes Treatment and ManagementPatient Safety and Medication Errors

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes

Leese, Graham P., Wang, Jixian, Broomhall, Janice, Kelly, Paul, Marsden, Andrew, Morrison, William, Frier, Brian M., Morris, Andrew D., For the DARTS/MEMO Collaboration·2003·Diabetes Care

DOI 10.2337/diacare.26.4.1176

Open this paper in CoChat — free account

Abstract

OBJECTIVE—To determine the incidence, predisposing factors, and costs of emergency treatment of severe hypoglycemia in people with type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS—Over a 12-month period, routinely collected datasets were analyzed in a population of 367,051 people, including 8,655 people with diabetes, to measure the incidence of severe hypoglycemia that required emergency assistance from Ninewells Hospital and Medical School (NHS) personnel including those in primary care, ambulance services, hospital accident and emergency departments, and inpatient care. Associated costs with these episodes were calculated. RESULTS—A total of 244 episodes of severe hypoglycemia were recorded in 160 patients, comprising 69 (7.1%) people with type 1 diabetes, 66 (7.3%) with type 2 diabetes treated with insulin, and 23 (0.8%) with type 2 diabetes treated with sulfonylurea tablets. Incidence rates were 11.5 and 11.8 events per 100 patient-years for type 1 and type 2 patients treated with insulin, respectively. Age, duration, and socioeconomic status were identified as risk factors for severe hypoglycemia. One in three cases were treated solely by the ambulance service with no other contact from health care professionals. The total estimated cost of emergency treatment of severe hypoglycemia was ≤£92,078 in one year. CONCLUSIONS—Hypoglycemia requiring emergency assistance from health service personnel is as common in people with type 2 diabetes treated with insulin as in people with type 1 diabetes. It is associated with considerable NHS resource use that has a significant economic and personal cost.

Integrity signals

Registry

Crossref · 10.2337/diacare.26.4.1176

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801
Deprivation and Health in Scotland
Tunstall-Pedoe, H. (1993) · Postgraduate Medical Journal · doi:10.1136/pgmj.69.814.665-a · Cited by 1,171
Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia.
Gold, A. E., Macleod, K. M., & Frier, B. M. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.697 · Cited by 810
Self-citation
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Hypoglycemia in the Diabetes Control and Complications Trial
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.2.271 · Cited by 746
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial
Abraira, C., Colwell, J. A., Nuttall, F. Q., Sawin, C. T., Nagel, N. J., Comstock, J. P., Emanuele, N. V., Levin, S. R., Henderson, W., Lee, H. S., et al. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1113 · Cited by 355
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345
Hypoglycemia in patients with type 2 diabetes mellitus
Miller, C. D., Phillips, L. S., Ziemer, D. C., Gallina, D. L., Cook, C. B., & El-Kebbi, I. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1653 · Cited by 341

Flagged first, then by citations

Show all 25 references

Sorted by citations

Items 101–200 of 550

Health Economic Evaluation of Type 2 Diabetes Mellitus: A Clinical Practice Focused Review
Liebl, A., Khunti, K., Orozco‐Beltrán, D., & Yale, J. (2015) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.4137/cmed.s20906 · Cited by 73
Gastric Electrical Stimulation with the TANTALUS® System in Obese Type 2 Diabetes Patients: Effect on Weight and Glycemic Control
Sanmiguel, C. P., Conklin, J. L., Cunneen, S. A., Barnett, P. S., Phillips, E. H., Kipnes, M. S., Pilcher, J., & Soffer, E. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300445 · Cited by 65
Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives
Boscari, F., & Avogaro, A. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09635-3 · Cited by 70
Low Socioeconomic Status is Associated with Increased Risk for Hypoglycemia in Diabetes Patients: The Diabetes Study of Northern California (DISTANCE)
Berkowitz, S. A., Karter, A. J., Lyles, C. R., Liu, J. Y., Schillinger, D., Adler, N. E., Moffet, H. H., & Sarkar, U. (2014) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2014.0106 · Cited by 67
Presence of Macroalbuminuria Predicts Severe Hypoglycemia in Patients With Type 2 Diabetes
Yun, J., Ko, S.-H., Ko, S.-H., Song, K., Ahn, Y., Yoon, K., Park, Y., & Ko, S. (2012) · Diabetes Care · doi:10.2337/dc12-1408 · Cited by 64
Uncovering undetected hypoglycemic events
Unger, J. (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s29367 · Cited by 62
Risk of severe hypoglycemia in sulfonylurea‐treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?
Schloot, N. C., Haupt, A., Schütt, M., Badenhoop, K. W. J., Laimer, M. W., Nicolay, C., Reaney, M. D., Fink, K., & Holl, R. W. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2722 · Cited by 62
Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It’s Time to Move On!
GENUTH, S. M. (2014) · Diabetes Care · doi:10.2337/dc14-0565 · Cited by 61
Pathophysiology and management of recurrent hypoglycaemia and hypoglycaemia unawareness in diabetes.
de Galan, B. E., Schouwenberg, B. J. J. W., Tack, C. J., & Smits, P. (2006) · PubMed · Cited by 61
Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England
Farmer, A. A., Brockbank, K., Keech, M. L., England, E., & Deakin, C. D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03657.x · Cited by 59
Predictors and Consequences of Severe Hypoglycemia in Adults with Diabetes - A Systematic Review of the Evidence
Bloomfield, H. E., Greer, N. L., Newman, D. R., MacDonald, R. H., Carlyle, M. H., FITZGERALD, P. J., Rutks, I. R., & Wilt, T. J. (2012) · Cited by 59
Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia
Holstein, A., Hahn, M., Patzer, O. M., Seeringer, A., Kovacs, P. L., & Stingl, J. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0976-1 · Cited by 59
Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin
Klarenbach, S. W., Cameron, C. G., Singh, S. K., & Ur, E. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110178 · Cited by 60
Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled trial with an open‐label, long‐term extension study
Seino, Y., Miyata, Y., Hiroi, S., Hirayama, M., & Kaku, K. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01620.x · Cited by 60
Emergency management of diabetes and hypoglycaemia
Brackenridge, A. (2006) · Emergency Medicine Journal · doi:10.1136/emj.2005.026252 · Cited by 58
Managing hypoglycaemia
Iqbal, A., & Heller, S. R. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.06.004 · Cited by 60
Trends in Emergency Department Visit Rates for Hypoglycemia and Hyperglycemic Crisis among Adults with Diabetes, United States, 2006-2011
Wang, J., Geiss, L. S., Williams, D. E., & Gregg, E. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134917 · Cited by 59
Self-citation
The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys
Fulcher, G. R., Singer, J., Limones, R. C., Filho, F. F., MAFFEI, L. E., Snyman, J. S., & Brod, M. I. (2014) · Journal of Medical Economics · doi:10.3111/13696998.2014.946992 · Cited by 57
An observational study of patient characteristics and mortality following hypoglycemia in the community
Elwen, F. R., Westwood, A. C., Clapham, L., Bottomley, M. J., Heller, S. R., James, C., Abbas, A., Baxter, P. D., & Ajjan, R. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000094 · Cited by 55
Hypoglycaemia in Type 2 diabetes
Heller, S. R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.026 · Cited by 55
Costs associated with emergency care and hospitalization for severe hypoglycemia
Veronese, G., Marchesini, G., Forlani, G., Saragoni, S., Esposti, L. D., Centis, E., & Fabbri, A. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.01.007 · Cited by 56
Area Deprivation and Regional Disparities in Treatment and Outcome Quality of 29,284 Pediatric Patients With Type 1 Diabetes in Germany: A Cross-sectional Multicenter DPV Analysis
Auzanneau, M., Lanzinger, S., Bohn, B., Kroschwald, P., Kuhnle-Krahl, U., Holterhus, P., Placzek, K., Hamann, J., Bachran, R., Rosenbauer, J., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0724 · Cited by 55
Insulin analogs: Glimpse on contemporary facts and future prospective
Sharma, A. K., Taneja, G., Kumar, A. R., Sahu, M., Sharma, G., Kumar, A., Sardana, S., & Deep, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.01.011 · Cited by 55
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes
Ray, J. A., Boye, K. S., Yurgin, N., Valentine, W. J., Roze, S., McKendrick, J., Tucker, D. M. D., FOOS, V., & Palmer, A. J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x178685 · Cited by 55
Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: A systematic review and meta-analysis
Alwafi, H. H., Alsharif, A. A., Wei, L., Langan, D., Naser, A. Y., Mongkhon, P., Bell, J. S., Ilomäki, J., AlMetwazi, M. S., Man, K. K. C., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108522 · Cited by 54
Incidence of and risk factors for severe hypoglycaemia in treated type 2 diabetes mellitus patients in the UK–a nested case-control analysis
Bruderer, S. G., Bodmer, M., Jick, S. S., Bader, G., Schlienger, R. G., & Meier, C. R. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12282 · Cited by 53
Hypoglycemia in Patients with Type 1 Diabetes: Epidemiology, Pathogenesis, and Prevention
Awoniyi, O., Rehman, R., & Dagogo-Jack, S. E. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0411-y · Cited by 55
Dementia in Diabetes: The Role of Hypoglycemia
Husain, K. H., Sarhan, S. F., AlKhalifa, H. K. A. A., Buhasan, A., Moin, A. S. M., & Butler, A. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129846 · Cited by 52
Drug-induced hypoglycaemia in type 2 diabetes
Inkster, B., Zammitt, N. N., & Frier, B. M. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.694424 · Cited by 52
Self-citation
The safety and efficacy of adding once‐daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries
Khunti, K., Caputo, S., Damcı, T., Dzida, G. J., Ji, Q., Kaiser, M., Karnieli, E., Liebl, A., Ligthelm, R. J., Nazeri, A., et al. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01665.x · Cited by 51
Hypoglycemia in type 2 diabetes
Banarer, S., & Cryer, P. E. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.003 · Cited by 51
Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Bonds, D. E., Kurashige, E. M., Bergenstal, R. M., Brillon, D. J., DOMANSKI, M. J., Felicetta, J. V., Fonseca, V. A., Hall, K., HRAMIAK, I. M., Miller, M. E., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.026 · Cited by 51
Incidence and care‐related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project
Barranco, R. J., Peralta, F. G., Abreu, C., Delgado‐Rodríguez, M., Palomares, R., Romero, F., Morales, C., de la Cal, M. A., García‐Almeida, J. M., Pasquel, F. J., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12843 · Cited by 50
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
Lukashevich, V., Schweizer, A., Foley, J. E., Dickinson, Groop, P., & Kothny, W. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s39300 · Cited by 50
Hypoglycemia Fear and Self-efficacy of Turkish Patients Receiving Insulin Therapy
Erol, Ö., & Enç, N. (2011) · Asian Nursing Research · doi:10.1016/j.anr.2011.12.001 · Cited by 49
Economic impact of hypoglycemia on healthcare in Spain
Brito-Sanfiel, M. Á., Diago, J. I., & Calderón, A. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.73 · Cited by 48
Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls
Pedersen‐Bjergaard, U., & Thorsteinsson, B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0965-1 · Cited by 48
Contributions of authors
Ender, S. A., Machner, A., Pap, G., Hubbe, J., Graßhoff, H., & Hw, N. (2007) · Acta Orthopaedica · doi:10.1080/17453670710014301 · Cited by 48
Hypoglycaemia: current management and controversies
Choudhary, P., & Amiel, S. A. (2011) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.068197 · Cited by 49
The increasing importance of environmental conditions in amyotrophic lateral sclerosis
Riancho, J., Bosque‐Varela, P., Pérez‐Pereda, S., Povedano, M., de Munaín, A. L., & Santurtún, A. (2018) · International Journal of Biometeorology · doi:10.1007/s00484-018-1550-2 · Cited by 49
Cost‐effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin – from the UK health care cost perspective
Evans, M., Wolden, M. L., Gundgaard, J., Chubb, B., & Christensen, T. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12250 · Cited by 46
Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? Yes, They Continue to Serve Us Well!
Abrahamson, M. J. (2014) · Diabetes Care · doi:10.2337/dc14-1945 · Cited by 46
Diabetes and Driving
Stork, A. D. M., van Haeften, T. W., & Veneman, T. F. (2006) · Diabetes Care · doi:10.2337/dc05-2232 · Cited by 46
Hypoglycemia
Alsahli, M., & Gerich, J. E. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.07.002 · Cited by 45
Glucagon as a Treatment of Severe Hypoglycemia
Pearson, T. L. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721707312400 · Cited by 45
Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: A retrospective study
Khunti, K. K., Fisher, H., Paul, S. K., Iqbal, M., Davies, M. J., & Siriwardena, A. N. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.01.001 · Cited by 44
Combining Information of Autonomic Modulation and CGM Measurements Enables Prediction and Improves Detection of Spontaneous Hypoglycemic Events
Cichosz, S. L., Frystyk, J., Tarnow, L., & Fleischer, J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814549830 · Cited by 45
A Cost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension versus Standard Pump Therapy for Hypoglycemic Unaware Patients with Type 1 Diabetes
Ly, T. T., Brnabic, A. J. M., Eggleston, A., Kolivos, A., McBride, M. E., Schrover, R., & Jones, T. W. (2014) · Value in Health · doi:10.1016/j.jval.2014.05.008 · Cited by 43
Cost-effectiveness of saxagliptin (Onglyza®) in type 2 diabetes in Sweden
Granström, O., Bergenheim, K., McEwan, P. C., Sennfält, K., & Henriksson, M. (2011) · Primary care diabetes · doi:10.1016/j.pcd.2011.09.003 · Cited by 43
Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial
Rosenstock, J., Fonseca, V. A., Schinzel, S., Dain, M., Mullins, P. R., & Riddle, M. C. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.04.003 · Cited by 44
Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England
McEwan, P., Thorsted, B. L., Wolden, M. L., Jacobsen, J., & Evans, M. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2014-000057 · Cited by 41
The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetes
Russell-Jones, D. L. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02465.x · Cited by 40
Hypoglycemia in Insulin-Treated Diabetes: A Case for Increased Vigilance
Unger, J., & Parkin, C. G. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2307 · Cited by 41
Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study
Giorda, C. B., Rossi, M. C., Ozzello, O., Gentile, S., Aglialoro, A., Chiambretti, A., Baccetti, F., Gentile, F. M., Romeo, F., Lucisano, G., et al. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.10.005 · Cited by 41
Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes
Yun, J., & Ko, S. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.1.6 · Cited by 41
Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control?
POGACH, L. M., Tiwari, A., Maney, M., Rajan, M., Miller, D. R., & Aron, D. C. (2007) · PubMed · Cited by 40
Causative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetes
Yanai, H. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.30 · Cited by 41
The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring
Bronstone, A. B., & Graham, C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633233 · Cited by 39
Chemical components of respirable particulate matter associated with emergency hospital admissions for type 2 diabetes mellitus in Hong Kong
Sun, S., Qiu, H., Ho, K., & Tian, L. (2016) · Environment International · doi:10.1016/j.envint.2016.10.022 · Cited by 39
Can a Tool That Automates Insulin Titration Be a Key to Diabetes Management?
Bergenstal, R. M., Bashan, E., McShane, M., Johnson, M. L., & Hodish, I. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0303 · Cited by 38
Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes
Chow, L. S., Zmora, R., Ma, S., Seaquist, E. R., & Schreiner, P. J. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000527 · Cited by 37
Economic burden of hypoglycemia in patients with type 2 diabetes
Liu, S., Zhao, Y., Hempe, J. M., Fonseca, V., & Shi, L. (2012) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.87 · Cited by 37
Incretin-based therapies: a new potential treatment approach to overcome clinical inertia in type 2 diabetes.
Nicolucci, A., & Rossi, M. C. (2008) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 37
The management of severe hypoglycemia by the emergency system: The HYPOTHESIS study
Marchesini, G., Veronese, G., Forlani, G., Forlani, G., Ricciardi, L. M., & Fabbri, A. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.05.012 · Cited by 37
Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes management
Dejager, S., & Schweizer, A. (2011) · Diabetes Therapy · doi:10.1007/s13300-010-0018-0 · Cited by 37
Counterpoint: Intensive Glucose Control and Mortality in ACCORD—Still Looking for Clues
Riddle, M. C. (2010) · Diabetes Care · doi:10.2337/dc10-1658 · Cited by 37
Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom
Woehl, A., Evans, M. L., Tetlow, A., & McEwan, P. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-24 · Cited by 37
Fear of hypoglycaemia and self-management in type 1 diabetes
Ahola, A. J., Saraheimo, M., Freese, R., Mäkimattila, S., Forsblom, C. M., & Groop, P. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.02.002 · Cited by 37
QT prolongation caused by insulin-induced hypoglycaemia – An interventional study in 119 individuals
Kacheva, S., Karges, B., Göller, K., Marx, N., Mischke, K., & Karges, W. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.021 · Cited by 38
Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review
Noh, R. M., Graveling, A. J., & Frier, B. M. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.589835 · Cited by 36
Self-citation
Increasing Trend in the Number of Severe Hypoglycemia Patients in Korea
Kim, J. T., Oh, T. J., Lee, Y. A., Bae, J. H., Kim, H. J., Jung, H. S., Cho, Y. M., Park, K. S., Lim, S., Jang, H. C., et al. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.2.166 · Cited by 35
Type 2 Diabetes Medication Review
Sterrett, J., Bragg, S. W., & Weart, C. W. (2016) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2016.01.019 · Cited by 38
Incidence rate and patient characteristics of severe hypoglycemia in treated type 2 diabetes mellitus patients in Japan: Retrospective Diagnosis Procedure Combination database analysis
Ikeda, Y., Kubo, T., Oda, E., Abe, M., & Tokita, S. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12778 · Cited by 36
The prevalence of hypoglycemia and its impact on the quality of life (QoL) of type 2 diabetes mellitus patients (The HYPO Study)
Rombopoulos, G., Hatzikou, M., Latsou, D., & Yfantopoulos, J. (2013) · HORMONES · doi:10.14310/horm.2002.1443 · Cited by 34
Toxicity of Metformin and Hypoglycemic Therapies
Akhter, M. S., & Uppal, P. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2019.08.004 · Cited by 36
Glycemic control and the risk of multiple microvascular diabetic complications.
Schellhase, K. G., Koepsell, T. D., & Weiss, N. S. (2005) · PubMed · Cited by 34
Treatment of Type 2 Diabetes in the Elderly
Munshi, M. N., Maguchi, M., & Segal, A. R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0269-4 · Cited by 33
Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
McEwan, P. C., Poole, C., Tetlow, T., Holmes, P., & Currie, C. J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167561 · Cited by 33
Population-Based Study of Severe Hypoglycemia Requiring Emergency Medical Service Assistance Reveals Unique Findings
Parsaik, A. K., Carter, R. E., Pattan, V., Myers, L. A., Kumar, H., Smith, S. A., Russi, C. S., Levine, J. A., Basu, A., & Kudva, Y. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600109 · Cited by 33
Dietary sugars versus glucose tablets for first-aid treatment of symptomatic hypoglycaemia in awake patients with diabetes: A systematic review and meta-analysis
Carlson, J. N., Schunder-Tatzber, S., Neilson, C. J., & Hood, N. (2017) · Emergency Medicine Journal · doi:10.1136/emermed-2015-205637 · Cited by 32
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling
Asgharzadeh, A., Patel, M., Connock, M. J., Damery, S. L., Ghosh, I., Jordan, M., Freeman, K., Brown, A., Court, R. A., Baldwin, S., et al. (2024) · Health Technology Assessment · doi:10.3310/jypl3536 · Cited by 32
Glucose Homeostasis – Mechanism and Defects
Szablewski, L. (2011) · InTech eBooks · doi:10.5772/22905 · Cited by 34
Complementing Insulin Therapy to Achieve Glycemic Control
Barnett, A. H. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0039-y · Cited by 33
Glucagon for hypoglycemic episodes in insulin-treated diabetic patients: a systematic review and meta-analysis with a comparison of glucagon with dextrose and of different glucagon formulations
Boido, A., Ceriani, V., & Pontiroli, A. E. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0665-0 · Cited by 32
Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated Type 2 diabetic patients
Ragia, G., Tavridou, A., Petridis, I., & Manolopoulos, V. G. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.04.017 · Cited by 32
Efficacy of Intermittently Scanned Continuous Glucose Monitoring in the Prevention of Recurrent Severe Hypoglycemia
Davis, T. M. E., Dwyer, P., England, M., Fegan, P. G., & Davis, W. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0331 · Cited by 31
Direct and indirect health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes
Aronson, R., Galstyan, G. R., Goldfracht, M., Sifri, S. A., Elliott, L., & Khunti, K. K. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.007 · Cited by 31
Continuous Glucose Monitoring in Small Animals
Surman, S. T., & Fleeman, L. M. (2013) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2013.01.002 · Cited by 31
Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy
Barnett, A. H. (2010) · Current Medical Research and Opinion · doi:10.1185/03007991003738063 · Cited by 34
Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: A multinational cross-sectional study
Naser, A. Y., Wong, I. C. K., Whittlesea, C., Alwafi, H. H., Abuirmeileh, A. N., Alsairafi, Z. K., Turkistani, F. M., Bokhari, N. S., Beykloo, M. Y., Al-Taweel, D. M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222275 · Cited by 30
Prescribing errors in diabetes
Cox, A. R., & Ferner, R. E. (2009) · The British Journal of Diabetes · doi:10.1177/1474651409103902 · Cited by 30
Hypoglycaemia with Oral Antidiabetic Drugs
Vlckova, V., Cornelius, V. R., Kasliwal, R., Wilton, L., & Shakir, S. (2009) · Drug Safety · doi:10.2165/00002018-200932050-00004 · Cited by 30
Plasma glucose responses in recreational divers with insulin-requiring diabetes.
Dear, G., Pollock, N. W., Uguccioni, D., Dovenbarger, J. A., Feinglos, M. N., & Moon, R. E. (2004) · PubMed · Cited by 30
The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
Kim, G., Oh, S. W., Jin, S., Hur, K. Y., Kim, J. H., & Lee, M. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1353080 · Cited by 30
Driving and insulin‐treated diabetes: who knows the rules and recommendations?
Watson, W., Currie, T., Lemon, J., & Gold, A. (2007) · Practical Diabetes · doi:10.1002/pdi.1097 · Cited by 29
Incidence Trends and Predictors of Hospitalization for Hypoglycemia in 17,230 Adult Patients With Type 1 Diabetes: A Danish Register Linkage Cohort Study
Ishtiak‐Ahmed, K., Carstensen, B., Pedersen‐Bjergaard, U., & Jørgensen, M. E. (2016) · Diabetes Care · doi:10.2337/dc16-0862 · Cited by 29
Reducing hypoglycaemia with insulin analogues
Heller, S. R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802175 · Cited by 30
Minimizing Morbidity of Hypoglycemia in Diabetes
Chung, S. T., & Haymond, M. W. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296814547518 · Cited by 28
Acute Management and Outcomes of Patients with Diabetes Mellitus Presenting to Canadian Emergency Departments with Hypoglycemia
Rowe, B. H., Singh, M., Villa‐Roel, C., Leiter, L. A., HRAMIAK, I. M., Edmonds, M. L., Lang, E., Sivilotti, M. L. A., Scheuermeyer, F. X., Worster, A., et al. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.09.084 · Cited by 28
Hypoglycaemic episodes in patients with type 2 diabetes – risk factors and associations with patient-reported outcomes: The PANORAMA Study
Simon, D., de Pablos-Velasco, P. L., Parhofer, K. G., Gonder-Frederick, L. A., Duprat-Lomon, I., Vandenberghe, H., Eschwège, É., & Bradley, C. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.08.007 · Cited by 28

Authors: Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration
Affiliations: Ninewells Hospital (GB)
Scottish Ambulance Service, Tayside Division, Dundee, U.K.
Edinburgh Royal Infirmary (GB)
ORCID: Leese, Graham P.
Wang, Jixian
Morrison, William
Frier, Brian M.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2003-04-01
Volume: 26
Issue: 4
Pages: 1176-1180
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.26.4.1176
OpenAlex: W2107648636
Cited by: 559
References: 25
Citations by year: 2026: 3 · 2025: 6 · 2024: 11 · 2023: 10 · 2022: 9 · 2021: 18 · 2020: 21 · 2019: 25 · 2018: 25 · 2017: 35 · 2016: 43 · 2015: 60 · 2014: 38 · 2013: 35 · 2012: 37
FWCI: 10.97
Type: journal article
Language: en
Open access: closed
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords: severe hypoglycemia, type 1 diabetes, type 2 diabetes, insulin therapy, emergency treatment, ambulance services, incidence, risk factors, socioeconomic status, health care costs, NHS resource use
MeSH terms: Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Emergencies, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Middle Aged, Scotland, Body Mass Index, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks